Theratechnologies Inc 's ability to collect accounts receivable sequentially worsen to 22.94, indicating more challenging environment then in the third quarter 2024, but still, it is a far cry from any concerns. Theratechnologies Inc 's Accounts Receivable average collection period in the Nov 30 2024 quarter, has increased to 16 days, from 14 days, in the 0 quarter.

If we take a look into Healthcare sector 35 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 378, from overall ranking in the third quarter 2024 at 919.

What is Receivable Turnover Ratio?
What is Theratechnologies Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

THTX Receivables Turnover Ratio	(Nov 30 2024) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Nov 30 2023) IV. Quarter
Y / Y Receivable Change	16.99 %	-	-	-	20.07 %
Y / Y Revenue Change	5.02 %	-	-	-	29.34 %
Receivable Turnover Ratio (TTM)	22.94	25.56	25.56	25.56	25.56
THTX's Total Ranking	# 378	# 919	#	#	#
Accounts Receivable average collection period days	16	14	14	14	14
Seq. Receivable Change	-	-	-	-	-
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 13
Healthcare Sector	# 36
Overall Market	# 378

Receivable Turnover Ratio Statistics
High	Average	Low
1.61	1.07	0.54
(Nov 30 2024)		(Nov 30 2019)

THTX Company Profile • Back to THTX Efficiency Comparisons • Compare THTX Receivables Turnover Ratio to its Competitors

Financial Statements
Theratechnologies Inc 's Accounts Receivable	$ 15 Millions	Visit THTX's Balance sheet
Theratechnologies Inc 's Sales TTM	$ 86 Millions	Visit THTX's Income Statement
Sources of THTX's Revenues		Visit THTX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
THTX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
THTX's Growth Rates	THTX's Roa	THTX's Inventory Turnover Ratio	THTX's Dividend Comparisons
THTX's Profitability Ratios	THTX's Roi	THTX's Asset Turnover Ratio	THTX's Dividend Growth
THTX's Valuation Ratios	THTX's Roe	THTX's Financial Strength Ratios	THTX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Nov 30 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Nov 30 2024	Receivable at quarter ending Nov 30 2024
Petvivo Holdings Inc	15.73	$ 0.956 Millions	$ 0.061 Millions
Mannkind Corporation	15.59	$ 285.504 Millions	$ 18.312 Millions
Medinotec Inc	15.50	$ 8.947 Millions	$ 0.577 Millions
Nexalin Technology Inc	15.48	$ 0.169 Millions	$ 0.011 Millions
Cervomed Inc	15.47	$ 9.738 Millions	$ 0.630 Millions
Waters Corporation	15.20	$ 2,958.387 Millions	$ 194.592 Millions
Biofrontera Inc	14.59	$ 63.395 Millions	$ 4.346 Millions
Icu Medical Inc	14.57	$ 2,382.046 Millions	$ 163.441 Millions
Sangamo Therapeutics Inc	14.13	$ 57.800 Millions	$ 4.092 Millions
Inmed Pharmaceuticals Inc	14.12	$ 4.494 Millions	$ 0.318 Millions
China Pharma Holdings Inc	13.76	$ 4.529 Millions	$ 0.329 Millions
Chemed Corporation	13.32	$ 2,431.287 Millions	$ 182.485 Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________	13.23	$ 4.879 Millions	$ 0.369 Millions
Amylyx Pharmaceuticals Inc	13.13	$ 87.371 Millions	$ 6.655 Millions
Patterson Companies Inc	13.08	$ 6,511.680 Millions	$ 497.898 Millions
Qhslab Inc	12.98	$ 2.132 Millions	$ 0.164 Millions
Nrc Health	12.89	$ 143.060 Millions	$ 11.100 Millions
Rosecliff Acquisition Corp I	12.51	$ 29.581 Millions	$ 2.366 Millions
Spero Therapeutics Inc	12.36	$ 47.977 Millions	$ 3.883 Millions
Co diagnostics Inc	12.07	$ 3.915 Millions	$ 0.324 Millions
Teladoc Health Inc	11.97	$ 2,569.574 Millions	$ 214.724 Millions
Lexicon Pharmaceuticals Inc	11.82	$ 31.081 Millions	$ 2.629 Millions
Quipt Home Medical Corp	11.80	$ 429.306 Millions	$ 36.385 Millions
Corcept Therapeutics Inc	11.79	$ 675.040 Millions	$ 57.262 Millions
Dyadic International Inc	11.71	$ 3.495 Millions	$ 0.299 Millions
Integrated Biopharma Inc	11.57	$ 52.074 Millions	$ 4.500 Millions
Absci Corp	11.44	$ 4.534 Millions	$ 0.397 Millions
International Stem Cell Corporation	11.43	$ 9.085 Millions	$ 0.795 Millions
Scorpius Holdings inc	11.34	$ 6.243 Millions	$ 0.550 Millions
Lifeloc Technologies Inc	11.34	$ 8.538 Millions	$ 0.753 Millions

Date modified: 2026-09-02T18:17:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.